Efficacy and Safety Study of Cinacalcet for the Treatment of Hypercalcemia in Patients With Primary Hyperparathyroidism Unable to Undergo Parathyroidectomy

Clinical trial NCT00975221 · COMPLETED

Trial details

NCT number: NCT00975221
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hyperparathyroidism, Primary Hypercalcemia

Start date: 2010-03-10
Primary completion: 2012-07-12
Enrollment: 67

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.